Table 1.
Correlation of expression of VEGF-C, VEGF-D, and Flt-4 in cervical cancer tissues with clinicopathological parameters
Variables | n | VEGF-C | VEGF-D | Flt-4 | ||||||
(+) | (-) | P | (+) | (-) | P | (+) | (-) | P | ||
Catamenia | ||||||||||
Premenopause | 68 | 37 | 31 | NS | 42 | 26 | NS | 33 | 35 | NS |
Postmenopause | 29 | 19 | 10 | 17 | 12 | 18 | 11 | |||
Tumor size (cm) | ||||||||||
≤4 | 61 | 36 | 25 | NS | 35 | 26 | NS | 30 | 31 | NS |
>4 | 36 | 20 | 16 | 24 | 12 | 21 | 15 | |||
Stromal invasion | ||||||||||
≤2/3 | 40 | 22 | 18 | NS | 27 | 13 | NS | 24 | 16 | NS |
>2/3 | 57 | 34 | 23 | 32 | 25 | 27 | 30 | |||
FIGO stage | ||||||||||
I a | 16 | 10 | 6 | NS | 7 | 9 | NS | 9 | 7 | |
I b | 33 | 18 | 15 | 22 | 11 | 18 | 15 | |||
II a | 48 | 28 | 20 | 30 | 18 | 24 | 24 | |||
Histological grade | NS | |||||||||
HG1 | 21 | 9 | 12 | NS | 12 | 9 | NS | 10 | 11 | |
HG2 | 31 | 18 | 13 | 20 | 11 | 15 | 16 | |||
HG3 | 45 | 29 | 16 | 27 | 18 | 26 | 19 | |||
Lymph node metastasis | ||||||||||
Negative | 67 | 33 | 34 | 0.012 | 35 | 32 | 0.010 | 30 | 37 | 0.022 |
Positive | 30 | 23 | 7 | 24 | 6 | 21 | 9 | |||
LVI | ||||||||||
Negative | 39 | 16 | 23 | 0.006 | 18 | 21 | 0.015 | 14 | 25 | 0.007 |
Positive | 58 | 40 | 18 | 41 | 17 | 37 | 21 | |||
Histological cell type | ||||||||||
SCC | 81 | 46 | 35 | NS | 50 | 31 | NS | 43 | 38 | NS |
ADE | 16 | 10 | 6 | 9 | 7 | 8 | 8 |
Abbreviations: HG, histological grade; LVI, lymphatic vessel invasion; SCC, squamous cell carcinoma; and ADE, adenocarcinoma. P, chi-square test.